Sales are up 50% from prior quarter. So that is good but we need numbers. I was hoping for $250,000 in sales. The company needs cash to stop the bleeding of shares. I guess 2019 will be the real test. I think most important things for rest of year are the Mexican deal and lawsuit wins. I understood part of the reason shares were diluted so high was to overcome voting strength by Lilly Li. Hoping to close all lawsuits and see at least a 25% share reduction. Is that unrealistic to see by end of January?